Replication-defective RNA tumor viruses exhibiting both in vitro and in vivo transforming activity have been isolated from a number of mammalian species including the mouse (13) , rat (9, 11) , cat (7, 20) and woolly monkey (24) . Such viruses appear to represent genetic recombinants between nondefective "leukemia" or "helper" viruses and the host cell from which the transforming sequences were derived (6, 17, 26) . The contribution of the former is limited with one possible exception (4) to genes coding for nonglycosylated viral structural proteins located at the 5' terminus of the helper virus genome (2, 3, 10, 14) and possibly an additional, as yet undefined segment(s) from the 3' terminus. The host cell contribution to such recombinant viruses are unique transforming sequences known as onc or src genes (17) . Nondefective mammalian leukemia viruses are characterized by nonglycosylated structural proteins with molecular weights of 30,000 (p30), 15 ,000 (p15), 12 ,000 (p12), and 10,000 (plO) coded for by a viral gene designated gag (1, 2, 18, 23, 27) . Initial expression of the gag gene translational products occurs in the form of a high (65,000)-molecular-weight precursor in which the individual proteins are arranged as follows: NH2 p15-p12-p30-plO COOH (2, 16 (10) , whereas cells transformed by the S+L-isolate of Moloney sarcoma virus (MSV) express p15, p12, and p30 (2) .
In view of evidence that nonproductively transformed cells contain genetic material coding for viral structural proteins in addition to a gene(s) coding for putative transforming protein(s), it was reasoned that translation of such proteins might occur in the forn of common high-molecular-weight (MW) precursor polyproteins that would be subject to subsequent post-translational cleavage. In fact, analysis of cells nonproductively transformed by FeSV (10, 22) Competition immunoassays for MuLV gag gene structural proteins of 30,000 (p30), 15, 000 (p15), 12,000 (p12), and 10,000 (plO) MW, the pol-coded RNA-dependent DNA polymerase, and env-coded gp70 were performed as previously described (2; Reynolds et al., in press). Molecular size analysis of viral antigen expression in cells was performed by agarose gel filtration in the presence of 6 M guanidine-HCl (A-15 m) by methods described in detail previously (2) Extracts of T-8-transformed mink cells were subjected to molecular size analysis by gel filtration in the presence of 6 M guanidine-HCl, and individual column fractions were tested for MuLV p15 and p12. Over 90% of both p12 (Fig.  1A ) and p15 (data not shown) reactivities cochromatographed at an MW of around 100,000, with a small amount of reactivity for both proteins appearing at 25,000 MW. Similar analysis of AbLV-transformed mink cells revealed a major p12 (Fig. 1B) -and p15 (data not shown)-containing precursor at a somewhat higher MW (110,000 to 130,000) (Fig. 1B) . In contrast, in the case of S'L--transformed mink (Fig. 10) , rat, or human cells (data not shown), the highest-MW protein containing antigenic cross-reactivity with MuLV gag proteins occurred at an MW of around 57,000 and contained p15, p12, and p30 antigenic determinants.
Further characterization of virus-coded antigen expression in T-8 and AbLV nonproductively transforned mink cells was performed by immunoprecipitation and subsequent sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of [3S]methionine-labeled proteins. The results (Fig. 2) indicate the presence of virus-coded polyproteins of around 90,000 to 110,000 and 110,000 to 130,000 MW in T-8-and AbLV-transforned mink cells, respectively. In both cases, these proteins were efficiently precipitated by sera prepared against detergent-disrupted Rauscher MuLV or M-MuLV, but not by control goat sera or by high-titered sera directed against MuLV gp7O. Although in some experiments the AbLV-coded precursor was also precipitated by antibody to MuLV p30, the extent of such precipitation was extremely limited, indicating that the precursor contained at most only a small portion of MuLV p30. Moreover, in pulse-chase experiments, we have not, to date, detected appreciable levels ofan anti-p30 precipitable protein lacking p15 and p12 in either AbLV-or T-8-transformed mink cells. Thus, the possibility that the low levels of immunoprecipitation of the AbLV precursors by anti-MuLV p30 may be due to low titers of anti-p15 or p12 in the anti-p30 serum cannot be ruled out. The difference of about 20,000 in MW between the T-8-and AbLV-coded precursors may be due, at least in part, to differences in MW of their nonstructural components since the contribution of viral structural proteins other than p15 and p12 appears to be minimal. virus-coded polyprotein upon post-translational cleavage gives rise to a 25,000-MW component containing p15 and p12 and a second component of around 60,000 to 95,000 MW lacking detectable immunological reactivity with known virion structural components. In contrast, mink cells transformed by the S+L-strain of MSV express three gag proteins, p15, p12, p30, and possibly a portion of the envelope glycoprotein (gp7O), but lack evidence of a precursor containing nonstructural components. Similarly, analysis of a rat (NRK) cell clone nonproductively transformed by the woolly monkey sarcoma virus and expressing pi5, p12, and p30 has failed to reveal a precursor of greater than 55,000 MW (unpublished data). Thus, to date, identification ofhigh-MW virus-coded precursor polyproteins containing structural and nonstructural components has been limited to those transforming viruses coding for only the two amino terminal gag gene proteins, p15 and p12. To determine the generality of this phenomenon, it will be of interest to search for analogous precursors in mammalian cells nonproductively transformed by sarcoma viruses that express variable numbers of the gag gene products.
The nature of the nonstructural components of the various sarcoma virus-coded precursor polyproteins has not been conclusively established. For instance, such proteins could represent src gene translational products involved in malignant transfornation or could be coded by nontransforming cellular genes acquired by sarcoma virus isolates along with the src genes. Altematively, these polyproteins may be the product of in-phase deletions encompassing both VOL. 27, 1978 p30 and p10 and resulting in a read-through of the carboxy terminal portions of pol or env. Although the fact that neither pol nor env gene products were detected by competition immunoassay would tend to argue against such a model, the possibility that the major inmunological determinants measured in such assays are located in partially deleted amino terminal regions of these proteins cannot be ruled out. A final consideration is that of a frameshift mutation within the gag gene resulting in synthesis of a new protein(s). The major argument against this possibility is the low probability of a frameshift resulting in such extensive translation without encountering a termination codon. The fact that in the feline system the 60,000-MW component of the FeSV-coded precursor is immunologically reactive with certain antisera directed against the tumor-specific feline oncornavirus cell membrane antigen (22) favors the possibility that these newly described proteins are transformation specific.
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